The examination of appropriate switching dose of epoetin beta pegol from short-acting epoetin in the treatment of anemia in the patients on chronic hemodialysis.
Not Applicable
- Conditions
- Patients on chronic hemodialysis
- Registration Number
- JPRN-UMIN000007839
- Lead Sponsor
- Apheresis and Dialysis Center Keio University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with severe heart failure Patients who can not be obtained written informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin concentration, dose of epoetin beta pegol
- Secondary Outcome Measures
Name Time Method